Alternatively, non‐hepatocyte populations within the tumor microenvironment—such as endothelial cells, stellate cells, or immune cells—may play more dominant roles in metabolite exchange and buffering, thereby diminishing the impact of hepatocyte MCT1 deletion. The gene discussed is SLC16A1; the disease is neoplasm.